1. Home
  2. DVN vs PODD Comparison

DVN vs PODD Comparison

Compare DVN & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Devon Energy Corporation

DVN

Devon Energy Corporation

HOLD

Current Price

$36.24

Market Cap

22.9B

Sector

Energy

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$292.28

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DVN
PODD
Founded
1971
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
22.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
DVN
PODD
Price
$36.24
$292.28
Analyst Decision
Buy
Strong Buy
Analyst Count
20
19
Target Price
$43.37
$366.58
AVG Volume (30 Days)
8.0M
641.0K
Earning Date
02-17-2026
02-19-2026
Dividend Yield
2.79%
N/A
EPS Growth
N/A
N/A
EPS
4.24
3.45
Revenue
$16,554,000,000.00
$2,521,800,000.00
Revenue This Year
$13.18
$32.55
Revenue Next Year
N/A
$20.50
P/E Ratio
$8.12
$86.70
Revenue Growth
13.94
27.11
52 Week Low
$25.89
$230.05
52 Week High
$38.88
$354.88

Technical Indicators

Market Signals
Indicator
DVN
PODD
Relative Strength Index (RSI) 49.93 46.48
Support Level $34.23 $278.79
Resistance Level $38.19 $299.80
Average True Range (ATR) 1.06 6.27
MACD -0.16 1.93
Stochastic Oscillator 49.67 65.60

Price Performance

Historical Comparison
DVN
PODD

About DVN Devon Energy Corporation

Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two-thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. At the end of 2024, Devon reported net proved reserves of 2.2 billion barrels of oil equivalent. Net production averaged roughly 848,000 barrels of oil equivalent per day in 2024 at a ratio of 73% oil and natural gas liquids and 27% natural gas.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: